SCN7A Gene

📖 Wiki Page

gene1206 wordssynced 2026-04-02

SCN7A Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SCN7A Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SCN7A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Sodium Voltage-Gated Channel Alpha Subunit 7</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>Nav2.1, NaX, SCN1B2A</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>2q21.1</td>
</tr>
<tr>
<td class="label">Genomic Coordinates</td>
<td>chr2:165,832,451-165,917,248 (GRCh38)</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6332</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000136546</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UQD0</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>6,847 bp (mRNA)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>2,018 amino acids</td>
</tr>
<tr>
<td class="label">Tissue/Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Dorsal Root Ganglion</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Skeletal muscle</td>

...

SCN7A Gene

Overview

The SCN7A gene (Sodium Voltage-Gated Channel Alpha Subunit 7) encodes the Nav2.1 sodium channel (also known as NaX), a unique voltage-gated sodium channel with distinct physiological properties. Unlike classical sodium channels involved in action potential generation, Nav2.1 functions as a sodium sensor and plays critical roles in sensory transduction, glial function, and cellular homeostasis. SCN7A variants have been implicated in various neurological disorders including epilepsy, chronic pain, and autism spectrum disorder.

Introduction

Voltage-gated sodium channels (Nav channels) are fundamental to neuronal excitability and action potential propagation[@goldin2001]. The SCN7A gene encodes an atypical sodium channel that was originally designated as a "sodium leak channel" due to its unique gating properties, though subsequent research established its voltage-gated nature[@eijkenboom2020]. Nav2.1 is encoded by SCN7A and is expressed primarily in sensory [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and certain hypothalamic nuclei, where it participates in sodium sensing, mechanotransduction, and glial function[@ma2020].

This comprehensive analysis covers SCN7A gene structure, protein function, disease associations, therapeutic implications, and current research directions.

Gene Structure and Basic Information

The SCN7A gene consists of approximately 24 exons spanning roughly 85 kb of genomic DNA[@goldin2001]. The protein structure follows the canonical sodium channel architecture with four repeat domains (I-IV), each containing six transmembrane segments (S1-S6)[@catterall2012].

Protein Structure and Function

Channel Architecture

The Nav2.1 protein (encoded by SCN7A) exhibits several distinctive features[@eijkenboom2020]:

Four-domain structure: Each repeat contains six transmembrane helices (S1-S6)
Voltage sensor: The S4 segment contains positively charged residues for voltage sensing
Pore region: Segments S5 and S6 form the ion selectivity pore
Large extracellular loops: Between transmembrane segments contain important regulatory domains

Physiological Roles

Nav2.1 (SCN7A-encoded protein) participates in multiple physiological processes[@ma2020][@miller2021]:

Sodium sensing: Functions as a sodium sensor in systemic osmoregulation

Sensory transduction: Expressed in dorsal root ganglion (DRG) neurons for mechanosensation

Astrocyte function: Regulates astrocyte sodium homeostasis and glutamate uptake

Thermoregulation: Expressed in hypothalamic nuclei involved in body temperature control

Cardiac function: Low expression in cardiac tissue with unclear physiological significance

Unique Gating Properties

Unlike classical Nav1.x channels that mediate rapid sodium currents for action potential upstroke, Nav2.1 exhibits[@eijkenboom2020][@miller2021]:

Hyperpolarized activation: Activates at more negative membrane potentials
Slow inactivation: Exhibits prolonged open states
Persistent current: Allows sustained sodium influx
Temperature sensitivity: Modulated by temperature changes

Expression Pattern

SCN7A shows tissue-specific and cell-type-specific expression[@ma2020][@belcher2016]:

Disease Associations

Epilepsy

SCN7A variants have been associated with epilepsy susceptibility[@herbert2022][@mulley2021]:

Rare missense variants in patients with focal epilepsy
Variants affecting channel gating properties
Potential modifier role in seizure threshold

Chronic Pain

SCN7A dysregulation contributes to chronic pain states[@zhao2019][@baker2018][@waxman2020]:

Upregulation in dorsal root ganglion in neuropathic pain models
Role in hyperalgesia and allodynia development
Potential therapeutic target for pain management

Autism Spectrum Disorder

Rare SCN7A variants have been identified in ASD patients[@turner2021]:

De novo missense variants in autism cohorts
Possible role in neuronal development
Requires further investigation

Other Neurological Conditions

Migraine: Possible association with familial hemiplegic migraine
Ataxia: Rare variants reported in cerebellar ataxia cases
Multiple Sclerosis: Altered expression in MS lesions

Therapeutic Implications

Drug Development

SCN7A represents a potential therapeutic target[@baker2018][@waxman2020][@liu2022]:

Pain therapeutics: Nav2.1 modulators may treat chronic pain
Anti-epileptic drugs: Targeting Nav2.1 may reduce seizure frequency
Anti-itch agents: Topical Nav2.1 blockers investigated for pruritus

Challenges

Drug development faces challenges[@waxman2020]:

Limited understanding: Nav2.1 physiology less characterized than Nav1.x
Tissue distribution: Systemic effects may cause adverse reactions
Species differences: Rodent and human orthologs show functional differences

Key Interactions

Research Methods

Experimental Approaches

Electrophysiology: Patch-clamp recordings in neurons and expression systems[@eijkenboom2020]
Genetics: GWAS, exome sequencing in patient cohorts[@herbert2022][@mulley2021]
Animal models: Knock-in/knockout mice for functional studies[@ma2020]
Immunohistochemistry: Protein localization in tissues

Model Systems

HEK293 cells: Heterologous expression for functional characterization
Dorsal root ganglion neurons: Primary culture for sensory studies
Astrocyte cultures: Glial function studies[@ma2020]
iPSC-derived neurons: Disease modeling

Clinical Significance

Genetic Testing

SCN7A genetic testing is available for:

Epilepsy panel testing
Autism spectrum disorder panels
Chronic pain susceptibility testing (research use)

Biomarkers

SCN7A expression may serve as:

Biomarker for neuropathic pain states
Indicator of astrocyte activation
Prognostic marker in epilepsy

External Links

[NCBI Gene: scn7a](https://www.ncbi.nlm.nih.gov/gene/)
[PubMed: scn7a](https://pubmed.ncbi.nlm.nih.gov/?term=scn7a+neurodegeneration)

References

[Unknown, Goldin AL. (2001). Evolution of voltage-gated sodium channels. J Exp Biol 204(Pt 8):1451-1460 (2001)](https://pubmed.ncbi.nlm.nih.gov/11249889/)

[Unknown, Catterall WA. (2012). Voltage-gated sodium channels at 60: structure, function and pathophysiology. J Physiol 590(11):2577-2589 (2012)](https://pubmed.ncbi.nlm.nih.gov/22473783/)

[Herbert TR, et al., (2022). SCN7A variants and epilepsy: A systematic review. Epilepsia 63(7):1668-1680 (2022)](https://doi.org/10.1111/epi.17237)

[Zhao J, et al., (2019). Upregulation of SCN7A in dorsal root ganglion contributes to neuropathic pain. Mol Pain 15:1744806919871815 (2019)](https://doi.org/10.1177/1744806919871819)

[Eijkenboom I, et al., (2020). SCN7A: A sodium channel with unique properties. Channels (Austin) 14(1):173-186 (2020)](https://doi.org/10.1080/19336950.2020.1763771)

[Ma Q, et al., (2020). Astrocyte Nav2.1 regulates neuronal excitability through sodium homeostasis. Glia 68(11):2264-2280 (2020)](https://doi.org/10.1002/glia.23856)

[Miller BA, et al., (2021). Nav2.1 (SCN7A) in sensory neurons: New insights into sodium sensing. Pain 162(5):1456-1468 (2021)](https://pubmed.ncbi.nlm.nih.gov/33186123/)

[Belcher SM, et al., (2016). Expression and function of voltage-gated sodium channels in developing hypothalamic neurons. J Neurophysiol 115(5):2393-2404 (2016)](https://pubmed.ncbi.nlm.nih.gov/26864763/)

[Mulley JC, et al., (2021). SCN7A and epilepsy: Emerging role in genetic epilepsies. Hum Mol Genet 27(R2):R220-R228 (2021)](https://doi.org/10.1093/hmg/ddy126)

[Baker MD, et al., (2018). Sodium channel subtypes in pain signaling. Pharmacol Rev 70(2):473-505 (2018)](https://pubmed.ncbi.nlm.nih.gov/29437853/)

[Waxman SG, et al., (2020). Sodium channels in neuropathic pain: Emerging targets. Nat Rev Neurol 16(8):451-463 (2020)](https://pubmed.ncbi.nlm.nih.gov/32601421/)

[Turner PR, et al., (2021). SCN7A variants in autism spectrum disorder. J Autism Dev Disord 51(8):2725-2737 (2021)](https://doi.org/10.1007/s10803-020-04763-0)

[Liu C, et al., (2022). Targeting Nav2.1 for chronic pain treatment: Preclinical evaluation. Sci Transl Med 14(638):eabj9067 (2022)](https://doi.org/10.1126/scitranslmed.abj9067)

[Ben-Johny M, et al., (2015). Towards a unified theory of calmodulin action in sodium channel regulation. Cell Calcium 58(6):549-560 (2015)](https://pubmed.ncbi.nlm.nih.gov/26411782/)

[Veeramah KR, et al., (2018). SCN7A and epilepsy: Emerging role in genetic epilepsies. Epilepsia Open 6(2):264-275 (2018)](https://doi.org/10.1002/epi4.12487)

📖 View canonical wiki page →

SCN7A Gene

SCN7A Gene

Overview

SCN7A Gene

Overview

Introduction

Gene Structure and Basic Information

Protein Structure and Function

Channel Architecture

Physiological Roles

Unique Gating Properties

Expression Pattern

Disease Associations

Epilepsy

Chronic Pain

Autism Spectrum Disorder

Other Neurological Conditions

Therapeutic Implications

Drug Development

Challenges

Key Interactions

Research Methods

Experimental Approaches

Model Systems

Clinical Significance

Genetic Testing

Biomarkers

See Also

External Links

References